secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELLAS Life Sciences Group, Inc. (SLS)
CIK:        0001390478
Form:       8-K
Filed at:   2024-06-21T23:59:59+00:00
Accession:  0001104659-24-073957
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

SELLAS Life Sciences stockholders re-elect two Class II directors and ratify auditor at 2024 annual meeting
--------------------------------------------------------------------------------

- Scheinberg and Kalin re-elected as Class II directors (8.6M/8.8M for; 18.7M broker non-votes).
- Ratified Moss Adams LLP as FY2024 auditor: 27.8M for, 1.7M against, 0.5M abstain.
- Advisory 'say-on-pay' passed: 6.0M for, 4.8M against, 0.6M abstain; 18.7M broker non-votes.
- Quorum: 30.0M shares (51.95%) represented at meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1390478/000110465924073957/0001104659-24-073957-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1390478/000110465924073957/tm2417795d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-073957

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer